High levels of YKL-40 in the CSF have been repeatedly shown to differentiate between AD patients and controls [29, 33–38], even if the degree of increase in AD is lower than that found for, e.g., CSF tau or neurofilament light protein [6]. Here, CHI3L1 is linked to Alzheimer disease.